Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    Finland Germany Poland Romania Slovakia Spain
  • A study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder

    Recruiting

    2 1
    Bulgaria Czechia Poland
  • A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

    Recruiting

    2 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
  • A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

    Recruiting

    3 1
    Investigated Drugs:
    Czechia Finland Germany Poland Romania Slovakia +1
  • A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Italy Romania Spain
  • A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

    Recruiting

    2 1 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
  • Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

    Recruiting

    2 1
    Investigated Diseases:
    Sweden
  • Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany
  • Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Bulgaria Croatia Czechia Estonia Finland +10
  • Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

    Recruiting

    3 1
    Investigated Diseases:
    Czechia Germany Greece Ireland Poland